BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31337979)

  • 21. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
    Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II.
    Wei L; Dai Q; Zhou Y; Zou M; Li Z; Lu N; Guo Q
    Biochim Biophys Acta; 2013 Jun; 1830(6):3835-45. PubMed ID: 23500080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
    Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X
    Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling.
    Wang J; Ma S; Chen X; Zhang S; Wang Z; Mei Q
    Invest New Drugs; 2019 Oct; 37(5):828-836. PubMed ID: 30456603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer.
    Wei G; Xu Y; Peng T; Yan J; Wang Z; Sun Z
    J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28296008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
    Kang CG; Im E; Lee HJ; Lee EO
    Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
    Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
    J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baicalein Inhibits Orthotopic Human Non-Small Cell Lung Cancer Xenografts via Src/Id1 Pathway.
    Zhao Z; Liu B; Sun J; Lu L; Liu L; Qiu J; Li Q; Yan C; Jiang S; Mohammadtursun N; Ma W; Li M; Dong J; Gong W
    Evid Based Complement Alternat Med; 2019; 2019():9806062. PubMed ID: 30949224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells.
    Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2017 Nov; 37(11):6311-6319. PubMed ID: 29061814
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Alsharairi NA
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34069141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
    Tabasum S; Singh RP
    Chem Biol Interact; 2019 Apr; 303():14-21. PubMed ID: 30802432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.
    Murase R; Sumida T; Kawamura R; Onishi-Ishikawa A; Hamakawa H; McAllister SD; Desprez PY
    Cancer Lett; 2016 Jul; 377(1):11-6. PubMed ID: 27087608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.
    Cheng YJ; Lee YC; Chiu WC; Tsai JW; Su YH; Hung AC; Chang PC; Huang CJ; Chai CY; Yuan SS
    Oncotarget; 2014 Nov; 5(22):11564-75. PubMed ID: 25344919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumoral activity of the human-specific duplicated form of α7-nicotinic receptor subunit in tobacco-induced lung cancer progression.
    Cedillo JL; Bordas A; Arnalich F; Esteban-Rodríguez I; Martín-Sánchez C; Extremera M; Atienza G; Rios JJ; Arribas RL; Montiel C
    Lung Cancer; 2019 Feb; 128():134-144. PubMed ID: 30642446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
    Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
    Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
    Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of flavonoids extracted from Scutellaria baicalensis Georgi on hemin-nitrite-H2O2 induced liver injury.
    Zhao Y; Li H; Gao Z; Gong Y; Xu H
    Eur J Pharmacol; 2006 Apr; 536(1-2):192-9. PubMed ID: 16574098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
    Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
    Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.